Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasiglifam Efficacy and Safety in Type 2 Diabetes
NCT01982253Phase 2Terminated
- Sponsor
- Takeda
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Oct 2013; status: terminated.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01982253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01982253.